Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta
Autor: | Collins, SL, Alemdar, B, van Beekhuizen, Heleen, Bertholdt, C, Braun, T, Calda, P, Delorme, P, Duvekot, J.J., Gronbeck, L, Kayem, G, Langhoff-Roos, J, Marcellin, L, Martinelli, P, Morel, O, Mhallem, M, Morlando, M, Noergaard, LN, Nonnenmacher, A, Pateisky, P, Petit, P, Rijken, MJ, Ropacka-Lesiak, M, Schlembach, D, Sentilhes, L, Stefanovic, V, Strindfors, G, Tutschek, B, Vangen, S, Weichert, A, Weizsacker, K, Chantraine, F, Is, AIP |
---|---|
Přispěvatelé: | Obstetrics & Gynecology, Obstetrics and Gynaecology, University of Helsinki, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, University of Oxford [Oxford], Karolinska University Hospital [Stockholm], Erasmus University Medical Center [Rotterdam] (Erasmus MC), Imagerie Adaptative Diagnostique et Interventionnelle (IADI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Obstétrique et de Gynécologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Freie Universität Berlin, Humboldt-Universität zu Berlin, Charles University [Prague] (CU), Maternité Port-Royal [CHU Cochin], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Copenhagen = Københavns Universitet (KU), Service de Gynécologie-Obstétrique [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Service de Gynécologie et Obstétrique [Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Università degli studi di Napoli Federico II, Cliniques Universitaires Saint-Luc [Bruxelles], Medizinische Universität Wien = Medical University of Vienna, Centre Hospitalier Universitaire de Liège (CHU-Liège), University Medical Center [Utrecht], Poznan University of Medical Sciences [Poland] (PUMS), Hôpital Pellegrin, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], Institute of Clinical Medicine [Oslo], Faculty of Medicine [Oslo], University of Oslo (UiO)-University of Oslo (UiO), Collins, S. L., Alemdar, B., van Beekhuizen, H. J., Bertholdt, C., Braun, T., Calda, P., Delorme, P., Duvekot, J. J., Gronbeck, L., Kayem, G., Langhoff-Roos, J., Marcellin, L., Martinelli, P., Morel, O., Mhallem, M., Morlando, M., Noergaard, L. N., Nonnenmacher, A., Pateisky, P., Petit, P., Rijken, M. J., Ropacka-Lesiak, M., Schlembach, D., Sentilhes, L., Stefanovic, V., Strindfors, G., Tutschek, B., Vangen, S., Weichert, A., Weizsacker, K., Chantraine, F., Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'obstétrique |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Delphi Technique
Placenta medicine.medical_treatment increta Guideline Oxytocin Conservative Treatment placenta accreta spectrum 0302 clinical medicine PERIPARTUM HYSTERECTOMY Uterine artery embolization 3123 Gynaecology and paediatrics Adrenal Cortex Hormones Pregnancy 030202 anesthesiology Abnormally invasive placenta Oxytocics Obstetrics and Gynaecology Medicine 030212 general & internal medicine Non-U.S. Gov't ComputingMilieux_MISCELLANEOUS reproductive and urinary physiology accreta 030219 obstetrics & reproductive medicine medicine.diagnostic_test Obstetrics Mortality rate Research Support Non-U.S. Gov't Obstetrics and Gynecology Gestational age Disease Management Morbidly adherent placenta 3. Good health Hospitalization medicine.anatomical_structure Practice Guideline SURGICAL-MANAGEMENT Female Stents guideline CESAREAN-SECTION SEVERE POSTPARTUM HEMORRHAGE medicine.medical_specialty Evidence-based practice placenta Placenta Accreta/therapy Accreta Gestational Age [SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine Placenta Accreta Adrenal Cortex Hormones/therapeutic use Research Support Hysterectomy Patient Positioning 03 medical and health sciences FIGO CONSENSUS GUIDELINES abnormally invasive placenta [INFO.INFO-IM]Computer Science [cs]/Medical Imaging BAKRI BALLOON TAMPONADE Journal Article Humans Intensive care medicine Watchful Waiting Oxytocics/therapeutic use morbidly adherent placenta Postpartum Hemorrhage/prevention & control UTERINE ARTERY EMBOLIZATION Increta Cesarean Section business.industry Postpartum Hemorrhage Balloon catheter Cystoscopy SUBSEQUENT PREGNANCIES percreta Percreta HYSTEROSCOPIC RESECTION Ureter Oxytocin/therapeutic use business [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology CONSERVATIVE MANAGEMENT |
Zdroj: | American Journal of Obstetrics and Gynecology, 220(6), 511. Mosby Inc. American Journal of Obstetrics and Gynecology, 220(6), 511-526. Mosby Inc. American journal of obstetrics and gynecology, 220(6), 511-526. Mosby Inc. American Journal of Obstetrics and Gynecology American Journal of Obstetrics and Gynecology, Elsevier, 2019, 220 (6), pp.511-526. ⟨10.1016/j.ajog.2019.02.054⟩ American Journal of Obstetrics and Gynecology, Vol. 220, no.6, p. 511-526 (2019) |
ISSN: | 0002-9378 1097-6868 |
Popis: | The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians’ understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management. |
Databáze: | OpenAIRE |
Externí odkaz: |